| ID | Sequence | Length | GC content |
|---|---|---|---|
| GACCGGCUGCCUGGCUGACUUACAGCAGUCAGACUCUGACAGGAUCAUG… | 1728 nt | 0.4010 | |
| GACCGGCUGCCUGGCUGACUUACAGCAGUCAGACUCUGACAGGAUCAUG… | 1289 nt | 0.4251 | |
| GACCGGCUGCCUGGCUGACUUACAGCAGUCAGACUCUGACAGGAUCAUG… | 1876 nt | 0.4025 |
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
A study in human prostate tissues from cadavers demonstrated that the TNFSF10 was not significantly upregulated at shorter postmortem intervals and was down-regulated at the initial 38-hour time point [Tolbert et al. DOI:10.1016/j.gene.2018.06.090]. In a separate investigation of human skin wound healing, the TNFSF10 was identified as a marker expressed in a specific spinous keratinocyte subtype (Spi-III) during the re-epithelialization process [Liu et al. DOI:10.1016/j.stem.2024.11.013].